Simple Warfarin Dosing Algorithm Study
NCT01008215 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 553
Last updated 2011-07-22
Summary
Can a simple and cost-free tool help family physicians to improve dosing of the blood thinner warfarin?
Warfarin is a blood thinner with a variable effect and requires regular blood monitoring and dose adjustments. Some family practices do not have the facilities or funding to use commercial tools than can assist with stabilizing the effect of warfarin. The investigators will test whether a simple and cost-free dosing tool can help these practices to improve warfarin management.
If this simple tool improves warfarin management, it will be freely available for practices in Canada and around the world. This will help physicians who have no access to more costly and/or complicated tools improve their warfarin dosing practice in a systematic fashion, and thereby maximize the health benefit of warfarin.
Conditions
- Warfarin Dosing
Interventions
- OTHER
-
Algorithm
Warfarin Dosing algorithm (paper and electronic version)
Sponsors & Collaborators
-
Population Health Research Institute
lead OTHER
Principal Investigators
-
Stuart Connolly · McMaster University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2011-04-30
- Completion
- 2011-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician?
NCT00735189 ·Status: COMPLETED ·Phase: PHASE4
-
Fearon Algorithm in Warfarin Patient Self-Management
NCT03911661 ·Status: COMPLETED ·Phase: NA
-
Clarification of Optimal Anticoagulation Through Genetics
NCT00839657 ·Status: COMPLETED ·Phase: PHASE3
-
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
NCT00927862 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Study of Warfarin Maintenance Dose in Chinese Patients
NCT01855737 ·Status: UNKNOWN
-
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
NCT02376803 ·Status: COMPLETED ·Phase: PHASE4
-
Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy
NCT00993200 ·Status: COMPLETED ·Phase: PHASE4
-
PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care
NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
NCT02592980 ·Status: UNKNOWN ·Phase: PHASE4
-
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
NCT00830570 ·Status: COMPLETED
-
Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy
NCT01033279 ·Status: COMPLETED ·Phase: NA
-
Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
NCT01610141 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Identification of Warfarin Maintenance Dosage
NCT01178034 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of 2012 Bioequivalence Standards for Warfarin
NCT02574754 ·Status: COMPLETED ·Phase: PHASE1
-
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
NCT00814177 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenetics of Warfarin in Puerto Ricans.
NCT01318057 ·Status: COMPLETED
-
Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist
NCT01348074 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenetic Study of Warfarin Dose-Response: a Prospective Trial
NCT00654823 ·Status: UNKNOWN
-
Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin
NCT02267408 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
NCT00005684 ·Status: COMPLETED
-
Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
NCT03147638 ·Status: UNKNOWN ·Phase: PHASE3
-
Genotype-Guided Warfarin Therapy Trial
NCT00904293 ·Status: COMPLETED ·Phase: NA
-
Patient Self Testing of Warfarin Therapy
NCT00594828 ·Status: UNKNOWN ·Phase: PHASE4
-
Reinforcement Learning for Warfarin Dosing
NCT03962400 ·Status: WITHDRAWN ·Phase: PHASE4
-
Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
NCT00700895 ·Status: UNKNOWN ·Phase: PHASE3